Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
37.42
-0.26 (-0.69%)
Sep 2, 2026, 11:28 AM EDT - Market open
Septerna Employees
Septerna had 123 employees as of June 30, 2026.
Employees
123
Change
n/a
Growth
n/a
Revenue / Employee
$803,919
Profits / Employee
-$197,041
Market Cap
1.75B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 123 | - | - |
| Mar 31, 2026 | 123 | 48 | 64.00% |
| Dec 31, 2025 | 130 | 55 | 73.33% |
| Dec 31, 2024 | 75 | - | - |
| Sep 30, 2024 | 73 | - | - |
| Jun 30, 2024 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Kardigan | 241 |
| Lakefront Biotherapeutics NV | 196 |
| Inhibrx Biosciences | 110 |
SEPN News
- 1 day ago - Septerna to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - GlobeNewsWire
- 14 days ago - Septerna price target raised to $48 from $38 at JPMorgan - TheFly
- 16 days ago - Septerna price target raised to $60 from $40 at H.C. Wainwright - TheFly
- 16 days ago - Septerna price target raised to $62 from $43 at Jones - TheFly
- 22 days ago - Septerna price target raised to $49 from $45 at Raymond James - TheFly
- 22 days ago - Septerna price target raised to $51 from $45 at Guggenheim - TheFly
- 22 days ago - Septerna reports Q2 EPS (29c), consensus (49c) - TheFly